A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
provide for clarification of requirements for the remanu-
facturing of medical devices, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Clarifying Remanufac-
4
turing to Protect Patient Safety Act of 2022’’. 
5
SEC. 2. CLARIFICATION OF REMANUFACTURING IN DEFINI-
6
TION. 
7
Section 510 of the Federal Food, Drug, and Cosmetic 
8
Act (21 U.S.C. 360) is amended— 
9
22:48 Mar 29, 2022
H7253
2 
•HR 7253 IH
(1) by subsection (a), by amending paragraph 
1
(1) to read as follows: 
2
‘‘(1) The term ‘manufacture, preparation, prop-
3
agation, compounding, or processing’ shall include 
4
the following: 
5
‘‘(A) Repackaging or otherwise changing 
6
the container, wrapper, or labeling of any drug 
7
package or device package in furtherance of the 
8
distribution of the drug or device from the 
9
original place of manufacture to the person who 
10
makes final delivery or sale to the ultimate con-
11
sumer or user. 
12
‘‘(B) Remanufacturing of any finished de-
13
vice by engaging in any act that could signifi-
14
cantly change the performance or safety speci-
15
fications, or intended use, of the finished device, 
16
including by significantly changing— 
17
‘‘(i) a sterilization method; 
18
‘‘(ii) a reprocessing instruction; 
19
‘‘(iii) a control mechanism, operating 
20
principle, or energy input or output; 
21
‘‘(iv) the anatomical location of use; 
22
or 
23
‘‘(v) the design.’’; and 
24
22:48 Mar 29, 2022
H7253
3 
•HR 7253 IH
(2) in subsection (j), by adding at the end the 
1
following: 
2
‘‘(6) The Secretary shall require that lists of devices 
3
reported pursuant to paragraph (2) specifically identify in 
4
any such list those devices that have been or are being 
5
remanufactured as described in subsection (a)(1)(B).’’. 
6
SEC. 3. INSPECTION OF DEVICE REMANUFACTURING ES-
7
TABLISHMENTS. 
8
Section 510(h) of the Federal Food, Drug, and Cos-
9
metic Act (21 U.S.C. 360(h)) is amended— 
10
(1) in paragraph (4)— 
11
(A) by redesignating subparagraph (H) as 
12
subparagraph (G); and 
13
(B) by inserting after subparagraph (F) 
14
the following: 
15
‘‘(G) Whether the establishment is reg-
16
istered as a remanufacturer or otherwise be-
17
lieved to be engaged in remanufacturing.’’; and 
18
(2) in paragraph (6)(A)— 
19
(A) in clause (i), by striking ‘‘and’’ at the 
20
end; 
21
(B) in clause (ii), by inserting ‘‘and’’ after 
22
the semicolon; and 
23
(C) by adding at the end the following: 
24
22:48 Mar 29, 2022
H7253
4 
•HR 7253 IH
‘‘(iii) the number of establishments reg-
1
istered as remanufacturers that the Secretary 
2
inspected in the previous calendar year;’’. 
3
SEC. 4. DEVICE REMANUFACTURING PUBLIC EDUCATION. 
4
(a) IN GENERAL.—The Secretary of Health and 
5
Human Services shall hold at least one public forum with-
6
in 12 months after the date of enactment of this Act, and 
7
shall take other ongoing steps as necessary, to increase 
8
public awareness of the requirements applicable to device 
9
remanufacturing, including— 
10
(1) holding webinars; and 
11
(2) engaging in other outreach to regulated in-
12
dustry, professional societies, advocacy groups, State 
13
and local governmental entities, and other stake-
14
holders. 
15
(b) REPORT.— 
16
(1) IN GENERAL.—Not later than 2 years after 
17
the date of enactment of this Act, the Secretary of 
18
Health and Human Services shall— 
19
(A) prepare and post on the website of the 
20
Food and Drug Administration a report with 
21
regard to the remanufacturing of devices; and 
22
(B) brief the Committee on Energy and 
23
Commerce of the House of Representatives and 
24
the Committee on Health, Education, Labor, 
25
22:48 Mar 29, 2022
H7253
5 
•HR 7253 IH
and Pensions of the Senate regarding the find-
1
ings of such report. 
2
(2) CONTENTS.—The report under paragraph 
3
(1) shall include the following: 
4
(A) A description of the activities carried 
5
out, and additional activities intended to be car-
6
ried out, under subsection (a). 
7
(B) The number of remanufacturing estab-
8
lishment registrations and remanufactured de-
9
vice listings under section 510 of the Federal 
10
Food, Drug, and Cosmetic Act (21 U.S.C. 
11
360), and any trends in such registrations and 
12
listings. 
13
(C) An assessment of whether the Food 
14
and Drug Administration should issue guidance 
15
for remanufacturers on compliance with the es-
16
tablishment registration and device listing re-
17
quirements of such section 510. 
18
(D) A summary of inspections carried out, 
19
warning letters and other advisory actions, and 
20
enforcement actions relating to remanufac-
21
turing establishments since the date of enact-
22
ment of this Act. 
23
(E) The status of actions undertaken pur-
24
suant to the report issued by the Secretary pur-
25
22:48 Mar 29, 2022
H7253
6 
•HR 7253 IH
suant to section 710 of the FDA Reauthoriza-
1
tion Act of 2017 (Public Law 115–52). 
2
(3) ANNUAL UPDATES.—On an annual basis, 
3
the Secretary of Health and Human Services shall— 
4
(A) update the report required by this sub-
5
section with regard to the information described 
6
in subparagraphs (B) and (D) of paragraph 
7
(2); and 
8
(B) post each such update on the website 
9
of the Food and Drug Administration. 
10
(c) DEFINITION.—In this section and section 5, the 
11
term ‘‘device’’ has the meaning given to such term in sec-
12
tion 201 of the Federal Food, Drug, and Cosmetic Act 
13
(21 U.S.C. 321). 
14
SEC. 5. ENHANCED COMMUNICATIONS REGARDING RE-
15
MANUFACTURING. 
16
The Secretary shall implement a process, to be posted 
17
on the website of the Food and Drug Administration, to 
18
receive through the Food and Drug Administration sub-
19
missions from State regulatory bodies and other State au-
20
thorities— 
21
(1) expressing concerns that an entity that is 
22
remanufacturing devices— 
23
22:48 Mar 29, 2022
H7253
7 
•HR 7253 IH
(A) is not registered under section 510 of 
1
the Federal Food, Drug, and Cosmetic Act (21 
2
U.S.C. 360); or 
3
(B) may otherwise be acting contrary to 
4
the Federal Food, Drug, and Cosmetic Act (21 
5
U.S.C. 301 et seq.); and 
6
(2) describing any actions taken by State au-
7
thorities against such entity. 
8
Æ 
22:48 Mar 29, 2022
H7253
